Olema Pharmaceuticals Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | +12.9% | +21.8% | +15,018.2% | -0.3% | -77.3% | +4.2% | +24.7% | |
| – | -100.0% | – | +412.0% | +18.3% | -8.4% | +30.9% | -22.1% | |
| – | +2,948.0% | +0.0% | +364.5% | +8.1% | – | – | – | |
| – | – | -222.8% | – | +6.8% | -119.5% | – | -69.7% | |
| – | +0.0% | +0.0% | +2,712.5% | -77.0% | -100.0% | – | -100.0% | |
| – | +0.0% | +0.0% | +491,753.6% | – | -105.3% | +1,828.0% | +66.5% | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | -65.8% | – | – | – | |
| – | +856.0% | +0.0% | -100.0% | – | – | – | – | |
| – | +6,721.5% | +0.0% | -99.6% | -65.8% | +27,928.4% | +101.5% | -21.4% | |
| – | -200.1% | – | -195.9% | – | +353.4% | +58.2% | -228.5% | |
| – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.